START FREE TRIAL

Technology & AI

Reality Check: Why Meta’s Smart Glasses Dream Isn’t The Growth Engine You Think It Is

When you look past the headlines, the story around Meta Platforms (NASDAQ:META) and...

Apple vs Micron: In a Memory Supercycle, Who Really Wins?

Memory prices are rising, supply remains tight, and the AI buildout is absorbing...

Is Nvidia’s China Comeback A Win Or A Structural RISK?

After months of lobbying, Nvidia Corp (NASDAQ:NVDA) finally received U.S. approval to resume...

M&A

Is Eli Lilly’s Orna Acquisition About RNA Or Something MUCH BIGGER?

Eli Lilly’s move to acquire Orna Therapeutics landed quietly, framed as another pipeline...

Is Apple Outflanking Meta With This Q.AI Move?

Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around...

Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?

Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech...

Consumer & Retail

Walmart Earnings Are Strong, But The Real Risk Isn’t In The Numbers

Walmart reports earnings on February 19, and few large-cap names enter the print...

Is Target’s Leadership RESET Enough To Change The Story?

Target’s new CEO moved quickly. An executive shake-up and hundreds of job cuts...

Is Amazon’s $50 Billion OpenAI Deal Really About AI — Or Just AWS Market Share?

Amazon is reportedly negotiating a $50 billion investment into OpenAI, a potential anchor...

Premium

Reality Check: Why Meta’s Smart Glasses Dream Isn’t The Growth Engine You Think It Is

When you look past the headlines, the story around Meta Platforms (NASDAQ:META) and...

Walmart Earnings Are Strong, But The Real Risk Isn’t In The Numbers

Walmart reports earnings on February 19, and few large-cap names enter the print...

U.S. Gas Prices Are Sliding—THESE Stocks Tell A Different Story!

U.S. natural gas prices have slipped into a different regime faster than many...

Healthcare

Did Moderna’s Flu Rejection Signal A Deeper FDA SHIFT?

Moderna’s seasonal flu vaccine application was refused review by the FDA, triggering an...

Is Eli Lilly’s Orna Acquisition About RNA Or Something MUCH BIGGER?

Eli Lilly’s move to acquire Orna Therapeutics landed quietly, framed as another pipeline...

Hims & Hers Just Went Big on Cancer—But the DOJ Is Watching

Hims & Hers used the Super Bowl stage to push its latest offering:...

Energy

U.S. Gas Prices Are Sliding—THESE Stocks Tell A Different Story!

U.S. natural gas prices have slipped into a different regime faster than many...

Is The Devon + Coterra $21 Billion Merger About Growth — Or Running Out of Rock?

Devon Energy just announced a $21.4 billion all-stock acquisition of Coterra, positioning itself...

Chevron Trump Venezuela Strategy in Crisis: Why Chevron Is Slamming the Brakes

It’s a standoff that pits shareholder caution against political ambition—and Chevron (NYSE:CVX) is...

Industrials

BorgWarner’s AI Pivot Is Powering A Re-Rating — But Where Could The Story Crack?

BorgWarner has quietly engineered one of the more dramatic sentiment reversals in the...

Did The Rio Tinto–Glencore Deal Fail Because Copper Is TOO Strategic?

Rio Tinto and Glencore walked away from merger talks that would have reshaped...

Howmet Buys CAM: The $1.8 Billion Bet That Could Reshape Aerospace

On December 22, 2025, Howmet Aerospace (NYSE:HWM) announced plans to acquire Consolidated Aerospace...

Miscellaneous

Trump’s Climate Reversal Just Reset The Earnings Map For Utilities, Autos, & Oil

The Trump administration has formally revoked the Environmental Protection Agency’s 2009 “endangerment finding,”...

Tri Pointe Homes Buyout Shock: Why Sumitomo Forestry Is Paying A 29% Premium

When Tri Pointe Homes (NYSE:TPH) announced that it had agreed to be acquired...

Gold & Silver Are Rallying — But The REAL Signal Is The Split!

Gold has pushed decisively above the psychological threshold that dominated market chatter, while...